BF Biosciences inks deal with Lucky Core

MG News | September 04, 2024 at 10:30 AM GMT+05:00

0:00

September 04, 2024 (MLN): BF Biosciences Limited (BFBL)has entered into a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI) for the products "Esopase IV 40 mg" & "Etipro IV 40 mg", the company's filing on PSX revealed.

BFBL is a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ).

In August, BF Biosciences successfully launched human insulin under the brand name "Ferulin".

BF Biosciences was established exclusively for the manufacture of biologicals and it is the first and only company in Pakistan currently to have a biotech manufacturing facility.

Copyright Mettis Link News

Related News

NICL's profit doubles to Rs2bn, declares 20% dividend

PSX issues revised calendar for Government Ijarah Saukuk auction

Major Solar installation completed at Kohinoor Mills facility

Name	Price/Vol	%Chg/NChg
KSE100	156,180.94 423.57M	0.51% 796.43
ALLSHR	95,690.82 1,354.89M	0.59% 557.25
KSE30	47,714.39 199.12M	0.52% 247.40
KMI30	229,722.09 134.66M	0.91% 2076.87
KMIALLSHR	64,420.07 581.33M	0.83% 532.01
BKTi	41,969.52 122.61M	0.50% 207.74
OGTi	31,991.76 10.82M	1.18% 372.62

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	115,730.00	116,415.00 115,215.00	155.00 0.13%
BRENT CRUDE	68.02	68.18 67.01	0.58 0.86%
RICHARDS BAY COAL MONTHLY	84.00	0.00 0.00	-0.40 -0.47%
ROTTERDAM COAL MONTHLY	93.40	93.50 93.15	0.55 0.59%
USD RBD PALM OLEIN	1,106.50	1,106.50 1,106.50	0.00 0.00%
CRUDE OIL - WTI	64.02	64.23 62.89	0.72 1.14%
SUGAR #11 WORLD	15.92	16.10 15.84	-0.08 -0.50%